Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 29, 2017

DrugPatentWatch Database Preview

Allopurinol - Generic Drug Details

« Back to Dashboard

What are the generic sources for allopurinol and what is the scope of allopurinol patent protection?

Allopurinol
is the generic ingredient in five branded drugs marketed by Watson Labs, Ipca Labs Ltd, Puracap Pharm, Mutual Pharm, Sun Pharm Inds, Superpharm, Apotex Inc, Northstar Hlthcare, Accord Hlthcare, Mylan, Indoco Remedies, Sandoz, Purepac Pharm, Sebela Ireland Ltd, Dr Reddys La, Sun Pharm Inds Inc, Abbott, Vintage Pharms, West-ward Pharms Int, and Mylan Institutional, and is included in thirty NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for allopurinol. Forty-six suppliers are listed for this compound.

Summary for Generic Name: allopurinol

Tradenames:5
Patents:1
Applicants:20
NDAs:30
Drug Master File Entries: see list21
Suppliers / Packagers: see list46
Bulk Api Vendors: see list151
Clinical Trials: see list44
Patent Applications: see list7,525
Therapeutic Class:Antigout Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:allopurinol at DailyMed

Pharmacology for Ingredient: allopurinol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare
ALLOPURINOL
allopurinol
TABLET;ORAL203154-001May 6, 2013ABRXNoNo► Subscribe► Subscribe
Superpharm
ALLOPURINOL
allopurinol
TABLET;ORAL070950-001Nov 30, 1988DISCNNoNo► Subscribe► Subscribe
Ipca Labs Ltd
ALLOPURINOL
allopurinol
TABLET;ORAL090637-002Mar 16, 2011ABRXNoNo► Subscribe► Subscribe
Mylan Institutional
ALOPRIM
allopurinol sodium
INJECTABLE;INJECTION020298-001May 17, 1996APRXYesYes► Subscribe► Subscribe
Sandoz
ALLOPURINOL
allopurinol
TABLET;ORAL070269-001Dec 31, 1985DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot